SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

Seroprevalence surveys suggest that more than a third and possibly more than half of the global population has been infected with SARS-CoV-2 by early 2022. As large numbers of people continue to be infected, the efficacy and duration of natural immunity in terms of protection against SARS-CoV-2 rein...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilz, Stefan, Theiler-Schwetz, Verena, Trummer, Christian, Krause, Robert, Ioannidis, John P.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824301/
https://www.ncbi.nlm.nih.gov/pubmed/35149106
http://dx.doi.org/10.1016/j.envres.2022.112911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824301/
https://www.ncbi.nlm.nih.gov/pubmed/35149106
http://dx.doi.org/10.1016/j.envres.2022.112911

Ejemplares similares